- About
-
Services
-
Offerings
- Offerings
- ADME and Bioanalytical Sciences
- Analytical Chemistry
- Assay Development
- Biochemical Assays
- Biophysical Assays
- Cell Based Assays
- Computational Chemistry
- Fragment and Compound Screening
- Integrated Drug Discovery Services
- Medicinal Chemistry
- Project Management and Consultancy Services
- Protein Expression and Purification Services
- Structural Biology
- Synthetic Chemistry
- Virtual screening
-
Research Phases
- Research Phases
- Hit Identification
- Hit to Lead
- Lead Optimisation
- Therapeutic Areas
- Target Classes
-
Approaches & Techniques
- Approaches & Techniques
- CDH (Target Gene Fragmentation)
- Cryogenic Electron Microscopy (Cryo-EM)
- Differential Scanning Fluorimetry (DSF) and nanoDSF Services
- Direct-to-Biology (D2B)
- Dynamic Light Scattering (DLS)
- eProtein Discovery
- Flow Cytometry
- Fragment Based Drug Discovery (FBDD)
- FragmentBuilder
- Grating-Coupled Interferometry
- High Throughput Screening
- Isothermal Titration Calorimetry (ITC)
- LeadBuilder
- Photoaffinity Labelling
- PoLiPa (Membrane Protein Solubilisation)
- Spectral Shift and MST Services
- Structure Based Drug Design (SBDD)
- Surface Plasmon Resonance (SPR)
- X-ray Crystallography
-
Offerings
- Library
- News & Events
- Careers
Enrich your medicines pipeline
The research partner that creates innovative solutions, builds dynamic relationships and enriches your medicines pipeline across a range of human diseases
Our Services
Our Vision and Mission
Our strong vision and mission statements underpin everything we do at Domainex. They guide our team with a common purpose that ensures we deliver outstanding drug discovery services to our clients.
Integrated drug discovery Services
We offer a truly integrated approach for a faster route to drug discovery. Our dedicated experts will work collaboratively with you to provide tailored scientific solutions.
King’s Award for Enterprise: International Trade 2023 winner
Domainex has been awarded a King’s Award for Enterprise recognising the company’s outstanding growth in international trade. The award is testament to the innovation, customer focus and dedication of the whole team.
Offerings
- Biophysical Assays
- Kinact / KI Assay for Irreversible Covalent Compounds
- Assay Development
- Reversible Covalent Inhibitor Binding Assay
- Fragment and Compound Screening
- Cell Based Assays
- Medicinal Chemistry
- Synthetic Chemistry
- Computational Chemistry
- Analytical Chemistry
- ADME and Bioanalytical Sciences
- Protein Expression and Purification Services
- Structural Biology
- Biochemical Assays
- Project Management and Consultancy Services
Research Phases
Therapeutic Areas
Target Classes
Approaches & Techniques
- LeadBuilder – Virtual Screening
- Spectral Shift and MST Services
- FragmentBuilder: Fragment-Based Drug Discovery and Design
- eProtein Discovery
- Innovative Polymer Lipid Particle (PoLiPa) Technology
- Dynamic Light Scattering (DLS)
- Structure Based Drug Design (SBDD)
- Molecular glues
- Ligand binding assays by Surface Plasmon Resonance (SPR) and/or Grating-Coupled Interferometry (GCI)
- Photoaffinity Labelling
- Differential Scanning Fluorimetry (DSF) and nanoDSF Services
- High Throughput Screening
- Cryogenic Electron Microscopy (Cryo-EM)
- Flow Cytometry
- X-ray Crystallography
- Isothermal Titration Calorimetry (ITC)
- CDH (Target Gene Fragmentation)
- Direct-to-Biology (D2B)
Case Studies
News
Events
LinkedIn Posts
Start your next project with Domainex
Contact one of our experts today